Researchers Establish Link Between Chromium VI and Stomach Cancer via a Meta-Analysis of Epidemiological Evidence

Share this content:

the Cancer Therapy Advisor take:

It has been previously established that there is a causal link between chromium VI (hexavalent chromium) and lung cancer, but the relationship between chromium VI and gastrointestinal cancer has not been well established.

Researchers from the California Environmental Protection Agency and Kaiser Permanente developed a study to identify whether or not the established human epidemiological research on chromium VI that has occupationally inhaled supports their hypothesis that there is a link between chromium VI and stomach cancer in humans.

The researchers conducted a thorough search and review of literature and studies and summarized the content of the current epidemiological findings related to inhaled chromium VI and stomach cancer via a meta-analysis. The meta analysis also explored heterogeneity sources.

The researchers found 76 individual relative risk estimates and 56 cohort and case-control studies related to an individual’s exposure to chromium VI and incidence of stomach cancer.  The summary relative risk for the combination of all studies was 1.27 (95% confidence interval [CI] 1.18 to 1.38).

When the researchers analysis was restricted to studies that only looked at the increase in risk of lung cancer the summary relative risk was higher, 1.41 (95% CI 1.18 to 1.69). The results of this study indicate that chromium VI is related to stomach cancer in humans, which was already established in studies of rodents.

Determining Dose-Limiting Toxicity in Patients with Oesophagogastric Cancer
Researchers studied link between chromium VI and stomach cancer in humans.
In this study, the authors aim was to examine whether the current human epidemiological research on occupationally inhaled Cr(VI) supports the hypothesis that Cr(VI) is associated with human stomach cancer. The results suggest that Cr(VI) is a stomach carcinogen in humans, which is consistent with the tumour results reported in rodent studies.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs